ConductScience.org, home

Paper1969115

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Volberding PA and 9 others. N Engl J Med, 1990. Cited by 1,272 papers, by iCite.

Cite this record

ConductScience Library. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Papers, record 1969115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1969115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
PubMed
Journal
N Engl J Med
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
1,272
iCite
Relative citation ratio, by iCite
43.3
iCite
Revised in PubMed
2013-11-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Volberding PAP A
2Lagakos SWS W
3Koch MAM A
4Pettinelli CC
5Myers MWM W
6Booth DKD K
7Balfour HH JrH H
8Reichman RCR C
9Bartlett JAJ A
10Hirsch MSM S

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4-Positive T-LymphocytesMajor topic
HIV InfectionsMajor topic
ZidovudineMajor topic
AIDS-Related Complex
Acquired Immunodeficiency Syndrome
Adult
Double-Blind Method
Female
Follow-Up Studies
Gene Products, gag
HIV Antigens
HIV Core Protein p24
Humans
Leukocyte Count
Male
Middle Aged
Patient Acceptance of Health Care
Randomized Controlled Trials as Topic
Viral Core Proteins

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00000736Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected IndividualsBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in1969114Early treatment for HIV: the time has come.https://conductscience.org/library/papers/1969114PubMed
Comment in2388674Zidovudine in asymptomatic HIV infection.https://conductscience.org/library/papers/2388674PubMed

Download CSV of comments and corrections

Cited by201

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,272 citations.

PMIDTitleJournalYearIn PapersSource
42338362Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".Stat Med2026https://conductscience.org/library/papers/42338362PubMed
42166427Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing.Brief Bioinform2026https://conductscience.org/library/papers/42166427PubMed
41849780Compressing Chemistry Reveals Functional Groups.J Chem Inf Model2026https://conductscience.org/library/papers/41849780PubMed
41369562Drug susceptibility of a clinical isolate of Balamuthia mandrillaris, a pathogenic free-living amoeba.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41369562PubMed
41013430Survival of kidney transplantation in people living with HIV/AIDS: a systematic review and meta-analysis.BMC Infect Dis2025https://conductscience.org/library/papers/41013430PubMed
39835565Drug Repurposing: A Conduit to Unravelling Metabolic Reprogramming for Cancer Treatment.Mini Rev Med Chem2025https://conductscience.org/library/papers/39835565PubMed
35229232It was 40 Years Ago Today: AIDS and the Brain.Neurocrit Care2022https://conductscience.org/library/papers/35229232PubMed
28369768Drug repurposing from the perspective of pharmaceutical companies.Br J Pharmacol2018https://conductscience.org/library/papers/28369768PubMed
27704821Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine (Emtriva, FTC).Acc Chem Res2016https://conductscience.org/library/papers/27704821PubMed
27182452A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey.For Immunopathol Dis Therap2015https://conductscience.org/library/papers/27182452PubMed
24192332Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.BMC Infect Dis2013https://conductscience.org/library/papers/24192332PubMed
23921730Trials challenging HIV drug doses could usher in huge cost cuts.Nat Med2013https://conductscience.org/library/papers/23921730PubMed
23877688Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23877688PubMed
23264786Prevalence, severity, and related factors of anemia in HIV/AIDS patients.J Res Med Sci2012https://conductscience.org/library/papers/23264786PubMed
22855396Daily quality control in CD3+ and CD4+ T cell estimation by the FACSCount system at a tertiary care center in south India.Clin Vaccine Immunol2012https://conductscience.org/library/papers/22855396PubMed
22451746Clinical significance and characterization of AZT-resistant strains of HIV-1.Can J Infect Dis1991https://conductscience.org/library/papers/22451746PubMed
21308456When to start antiretroviral therapy.Curr Infect Dis Rep2011https://conductscience.org/library/papers/21308456PubMed
21222041Statistical decisions and the interim analyses of clinical trials.Theor Med Bioeth2011https://conductscience.org/library/papers/21222041PubMed
21221397Early Clinical Signs and Symptoms of HIV Infection: Delaying progression to AIDS.Can Fam Physician1992https://conductscience.org/library/papers/21221397PubMed
21047391Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.J Int AIDS Soc2010https://conductscience.org/library/papers/21047391PubMed

See all 201 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
TMED210959PubTator's text mininghttps://conductscience.org/library/genes/10959NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1969115

GET https://conductscience.org/api/papers/v1/1969115/cited_by?page=2